Supplemental Figure 15 from GD2-Targeting CAR T-cell Therapy for Patients with GD2⁺ Medulloblastoma

Roselia Ciccone; Concetta Quintarelli; Antonio Camera; Michele Pezzella; Simona Caruso; Simona Manni; Alessio Ottaviani; Marika Guercio; Francesca Del Bufalo; Maria Cecilia Quadraccia; Domenico Orlando; Stefano Di Cecca; Matilde Sinibaldi; Mariasole Aurigemma; Laura Iaffaldano; Andrea Sarcinelli; Maria Luisa D'Amore; Manuela Ceccarelli; Francesca Nazio; Veronica Marabitti; Ezio Giorda; Marco Pezzullo; Cristiano De Stefanis; Andrea Carai; Sabrina Rossi; Rita Alaggio; Giada Del Baldo; Marco Becilli; Angela Mastronuzzi; Biagio De Angelis; Franco Locatelli

doi:10.1158/1078-0432.25956301

Abstract

Supplemental Figure 15. Orthotopic PDX mouse model of human MED-411 FH mCherry/Luc cell line to evaluate anti-tumor activity of CAR.GD2 T-cells and the in vivo modulation of GD2 expression.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Ciccone et al. (2024) studied this question.

synapsesocial.com/papers/68e66839b6db6435875f3c8f https://doi.org/10.1158/1078-0432.25956301

View Full Paper

Ask AI

Bookmark

Abstract

Supplemental Figure 15. Orthotopic PDX mouse model of human MED-411 FH mCherry/Luc cell line to evaluate anti-tumor activity of CAR.GD2 T-cells and the in vivo modulation of GD2 expression.

Supplemental Figure 15 from GD2-Targeting CAR T-cell Therapy for Patients with GD2⁺ Medulloblastoma

Abstract

Discussion

Cite This Study

Supplemental Figure 15 from GD2-Targeting CAR T-cell Therapy for Patients with GD2⁺ Medulloblastoma

Abstract

Discussion

Cite This Study

Keep reading

Keep reading